Matrix metalloproteinase-9 contributes to brain extravasation and edema in fulminant hepatic failure mice

Justin H Nguyen1, Satoshi Yamamoto, Jeffery Steers

  • 1Department of Transplantation, Division of Transplant Surgery, Mayo Clinic College of Medicine, 4205 Belfort Road, Suite 1100, Jacksonville, FL 32216, USA. nguyen.justin@mayo.edu

Journal of Hepatology
|February 7, 2006
PubMed
Abstract

Insights

Matrix metalloproteinase-9 (MMP-9) contributes to brain edema in fulminant hepatic failure (FHF). Inhibiting MMP-9 may prevent brain swelling and protect against FHF complications.

Area of Science:

  • Neuroscience
  • Hepatology
  • Biochemistry

Background:

  • Fulminant hepatic failure (FHF) can lead to coma and fatal brain edema.
  • The mechanisms of brain extravasation causing edema in FHF are not fully understood.
  • Matrix metalloproteinase-9 (MMP-9) is implicated in various brain injuries.

Purpose of the Study:

  • To investigate the role of MMP-9 in brain edema development during FHF.
  • To determine if MMP-9 contributes to brain extravasation in FHF.

Main Methods:

  • Assayed MMP-9 levels using SDS-PAGE and zymography.
  • Measured brain extravasation with Evans blue and brain water content.
  • Utilized azoxymethane-induced FHF model in mice, employing MMP inhibitor GM6001 and an MMP-9 antibody.

Main Results:

  • Active MMP-9 significantly increased with coma onset and brain extravasation in FHF mice.
  • Blocking MMP-9 attenuated brain extravasation, astrocytic swelling, and brain edema.
  • MMP-9 activity originated from the necrotic liver, not the brain.

Conclusions:

  • MMP-9 plays a role in the pathogenesis of brain extravasation and edema in FHF.
  • The liver is identified as the source of MMP-9 in FHF.
  • Inhibiting MMP-9 shows potential for protecting against brain edema in FHF.